As of close of business last night, Caribou Biosciences Inc’s stock clocked out at $4.50, down -0.88% from its previous closing price of $4.54. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 2338084 shares were traded.
Ratios:
To gain a deeper understanding of CRBU’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.97 and its Current Ratio is at 11.97. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.
On July 11, 2023, Truist started tracking the stock assigning a Buy rating and target price of $23.Truist initiated its Buy rating on July 11, 2023, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 406.42M and an Enterprise Value of 104.70M. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.79 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 3.04 whereas that against EBITDA is -0.93.
Stock Price History:
Over the past 52 weeks, CRBU has reached a high of $8.59, while it has fallen to a 52-week low of $3.44. The 50-Day Moving Average of the stock is 6.2787, while the 200-Day Moving Average is calculated to be 5.6762.
Shares Statistics:
It appears that CRBU traded 1.64M shares on average per day over the past three months and 1.68M shares per day over the past ten days. A total of 88.45M shares are outstanding, with a floating share count of 79.39M. Insiders hold about 12.10% of the company’s shares, while institutions hold 78.10% stake in the company. Shares short for CRBU as of Mar 15, 2024 were 10.07M with a Short Ratio of 6.14, compared to 9.69M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.15% and a Short% of Float of 11.69%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.4 for the current quarter, with a high estimate of -$0.35 and a low estimate of -$0.44, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.4 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.6 and -$2.03 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$2.05, with 6 analysts recommending between -$1.43 and -$2.97.
